ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
0.539
0.00
( 0.00% )
Updated: 02:14:27

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.539
Bid
0.535
Ask
0.538
Volume
250
0.539 Day's Range 0.539
0.483 52 Week Range 0.786
Market Cap
Previous Close
0.539
Open
0.539
Last Trade
190
@
0.539
Last Trade Time
02:00:07
Financial Volume
-
VWAP
-
Average Volume (3m)
254,495
Shares Outstanding
255,211,081
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
719.57M
Net Profit
-6.45M

About Geox SPA

Sector
Footwear, Except Rubber, Nec
Industry
Footwear, Except Rubber, Nec
Website
Headquarters
Biadene Di Montebelluna, Ita
Founded
-
Geox SPA is listed in the Footwear, Except Rubber sector of the Italian Stock Exchange with ticker GEO. The last closing price for Geox was 0.54 €. Over the last year, Geox shares have traded in a share price range of 0.483 € to 0.786 €.

Geox currently has 255,211,081 shares outstanding. The market capitalization of Geox is 137.56 € million.

GEO Latest News

Geox Profit Falls 19%; Costs, Currency Pressures Endure

Italian shoemaker Geox SpA (GEO.MI) said Thursday its first- quarter net profit fell a better-than-expected 18.9% to EUR43.4 million as its margins were hit by rising raw material and labor costs...

CORRECT: Geox Full-Year Ebitda Down 20%; Sees Hurdles In '11

Italian shoemaker Geox SpA (GEO.MI) Thursday said its 2010 full-year net profit fell 13% to EUR58 million and predicted rising raw material costs and currency fluctuations will pose challenges in...

Geox Fiscal Year 10 Ebitda Down 13%; Sees Hurdles In '11

Italian shoemaker Geox SpA (GEO.MI) Thursday said its 2010 full-year net profit fell 13% to EUR58 million and predicted rising raw material costs and currency fluctuations will pose challenges in...

Geox 9-Months Net Profit Down On Lower Revenue, Higher Costs

Italian shoemaker Geox SpA (GEO.MI) Friday said net profit fell 19% in the first nine months of the year, mainly due to lower sales and higher costs. The company said its net profit fell to...

UPDATE: Geox Maintains Full-Year Targets As 1st Half Profit Falls 33%

(Updates and rewrites, adding comment.) By Chiara Vasarri Of DOW JONES NEWSWIRES ROME (DOW JONES)--Italian shoemaker Geox SpA (GEO.MI) Thursday confirmed its full-year guidance after reporting a...

Geox First-Half Net Profit Falls 33% On Year

ROME (DOW JONES)--Italian shoemaker Geox SpA (GEO.MI) Thursday reported a 33% drop in first-half net profit on lower sales and costs related store openings. However, revenue in the second quarter...

Geox 1Q Net Profit Falls 26% On Lower Sales

ROME (DOW JONES)--Italian shoemaker Geox SpA (GEO.MI) Friday said its first-quarter net profit fell around 26% on lower sales, but said there are encouraging signs for future sales at its flagship...

Tod's Of Italy Says 2009 Revenue EUR713 Million, Up 0.8% Vs 2008

Italian luxury goods maker Tod's SpA (TOD.MI) said Wednesday it managed to boost sales last year despite the worst recession in decades. Full-year revenue in 2009 was EUR713 million, up 0.8...

Geox 9-Months Net Profit Down 33.4% Amid Slowing Sales

Italian shoemaker Geox SpA (GEO.MI) said its net profit dropped 33.4% in the first nine months of the year, mainly due to high costs related to the opening of new stores worldwide and slowing...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.026-4.60176991150.5650.5790.5292759240.54832137DE
40.0377.370517928290.5020.5790.48552678970.53559018DE
12-0.046-7.863247863250.5850.6060.4832544950.54690496DE
26-0.064-10.61359867330.6030.6160.4832343000.56768519DE
52-0.186-25.65517241380.7250.7860.4833883780.64965896DE
156-0.483-47.26027397261.0221.1960.4833983120.8093142DE
260-0.637-54.16666666671.1761.3940.455236190.86714113DE

GEO - Frequently Asked Questions (FAQ)

What is the current Geox share price?
The current share price of Geox is 0.539 €
How many Geox shares are in issue?
Geox has 255,211,081 shares in issue
What is the market cap of Geox?
The market capitalisation of Geox is EUR 137.56M
What is the 1 year trading range for Geox share price?
Geox has traded in the range of 0.483 € to 0.786 € during the past year
What is the reporting currency for Geox?
Geox reports financial results in EUR
What is the latest annual turnover for Geox?
The latest annual turnover of Geox is EUR 719.57M
What is the latest annual profit for Geox?
The latest annual profit of Geox is EUR -6.45M
What is the registered address of Geox?
The registered address for Geox is VIA FELTRINA CENTRO, 16, BIADENE DI MONTEBELLUNA, 31044
What is the Geox website address?
The website address for Geox is www.geox.biz
Which industry sector does Geox operate in?
Geox operates in the FOOTWEAR, EXCEPT RUBBER, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WART28DeodatoGallery SpA
0.0488 €
(8.44%)
14.1k
SOMSOMEC SpA
11.80 €
(7.76%)
20
ARTDeodatoGallery SpA
0.424 €
(7.61%)
60k
ESPEESPE SpA
2.60 €
(6.12%)
3.75k
GCOMGigliocom
1.05 €
(5.00%)
4k
WPAL26Palingeo SpA
0.20 €
(-13.04%)
700
CNFConafi SpA
0.265 €
(-6.36%)
38
MNLMonnalisa SPA
1.29 €
(-5.15%)
32.99k
RWYReway Group SpA
5.62 €
(-4.42%)
1.5k
1FCXFreeport McMoRan Inc
36.935 €
(-4.41%)
15
TITTelecom Italia SpA
0.2498 €
(-0.48%)
25.85M
ISPIntesa Sanpaolo Spa
3.8075 €
(-1.18%)
11.18M
SPMSaipem Spa
2.567 €
(-2.88%)
8.08M
ENELEnel Spa
6.757 €
(-0.65%)
4.18M
TITRTelecom Italia
0.2874 €
(-1.00%)
2.72M

Discussion

View Full Feed
lovethatgreen lovethatgreen 1 minute ago
You're a pos
RDGL
PC retired PC retired 7 minutes ago
Hi Mr Dorick. Simon D was of the opinion that there had been lawsuits over the original "earth engine" hoax. As you have noted this was a lot more blatant, ie 25Kw from magnets!! The current nonsense hints at off-grid power , rather than stating it in clear language.
FLCX
71chris71 71chris71 18 minutes ago
Usually thieves do not give information! In fact, Mr. Nixon, being the king of thieves, and I would add a scoundrel, has never sent anything! He is only interested in stealing
236T568 236T568 21 minutes ago
Very Sad

David Gergen, Adviser To 4 U.S. Presidents, Has Dementia

https://www.huffpost.com/entry/david-gergen-dementia_n_67647dd6e4b00aa16adf512f
rikkie rikkie 22 minutes ago
Look at Polariton and AMF! They have produced world class products in speed, consumption and size. Look at the patents LWLG has collected in photonics and polymers. Don't tell me this will just disappear. I remain optimistic about the polymer "perkinamine" and have higher expectations now that Yves
LWLG
fuagf fuagf 22 minutes ago
brooklyn13, My take on all of that is unchanged from shortly after i arrived here in 1967. Australia, like every other country, has bigoted people whether the bigotry is based on ethnicity, imagined race or religion. The antipathy against Israel at present is more based on the increasingly geno
Banjo50 Banjo50 33 minutes ago
BIG LOTS FOLDING THE TENT! TOLD YOU SO! COMPLETELY MISMANAGED FOR THE LASR FIVE YEARS!!!
BIGGQ
IVRT IVRT 37 minutes ago
I think the last BMXI carrot is Hall Cadwick. There is no other reason to delay. Cannot replace Hall because the ladder does not go any higher up. The delays have become a millstone around BMXI's neck. Either as you say the audit is fictitious or the audit must be done in January. There are no
BMXI
chereb19 chereb19 52 minutes ago
Isopet has been proven to be profitable
RDGL
QuantumTravesty QuantumTravesty 55 minutes ago
Thanks.
HIRU
knrorrel knrorrel 1 hour ago
very nice
QNCCF
GASMASK GASMASK 1 hour ago
What's/who's TA?
MRGE
JerryCampbell JerryCampbell 2 hours ago
Data entry error the previous day.

Someone mistakenly entered 8,000,000 instead of 800,000. The -7.2m corrects it.
NWBO
georgejjl georgejjl 2 hours ago
I guess that Anavex could have sales of $14 billion during the first full year after approval in 2026 by the EMA in the EU alone based on capturing a 25% market share of the 8 million people in the EU with Alzheimer’s disease at a prescription cost of $7,000 per year per patient.

Go
AVXL
jeunke22 jeunke22 2 hours ago
Thanks KCC , I am still very positive about my investment here. Doing business implies to understand when it is time to adapt to a given set of circumstances. No need to try to go through a wall, if you can go around it. I think that is what has changed here. A more practical and energetic way to g
LWLG
DMC8 DMC8 2 hours ago
Feeling burnout recently fellow shareholders?

Watch the youtube chat on how to manage burnout by Patrice Bonfiglio, President of Sarissa Capital Management LP.
https://youtu.be/wpFutxLn-wk?si=6Rm2JhCbHvgvUcsb
AMRN
lodas lodas 2 hours ago
jhdf51........never buy a Put or a Call option unless you are 100% sure of the outcome at expiration.... why? you only a 50% chance of success... said another way... you either win, or lose...... however by Selling a Put, or Call options, you have a 66% chance of winning, or 2 ways out of three...
COOP
pepeoil pepeoil 2 hours ago
Good morning shrimpers. Bwahaaaaaa. We are broke. Lol
THEDOG 17 THEDOG 17 2 hours ago
O and you may as well clock out because Bio was acquired!! Yeah if you can’t figure it out maybe you should read that report eagle just posted!!!! Acquisition!!!!! Let’s gooo
jhdf51 jhdf51 2 hours ago
My bird in the hand is COOP. Escrow is now a ROC
capable of carrying hopeful escrowers in its talons.

JHD
COOP
jhdf51 jhdf51 2 hours ago
It seems that people playing options are like people going to Vegas.. they never lose.

JHD
COOP
2018trader 2018trader 2 hours ago
Just keep buying the monopoly 7, I mean mag 7
SPY
TCI1 TCI1 2 hours ago
I can’t open the link to the CVS coverage for 2025, would like to see it as they dropped Vascepa in July.

Sleven have you seen any positive or negative changes?
CVS
TCI1 TCI1 2 hours ago
Well UHC has both IPE and Vascepa covered with PA so you would hope and expect all CVD indications to go to Vascepa. Not sure if this is a change or not but by using a PA UHC are exposing themselves to litigation if they prioritise generic for CVD. Of course this is based off insurers adhering to th
AMRN

Your Recent History

Delayed Upgrade Clock